HEADER ANTIVIRAL PROTEIN 01-DEC-20 7B3O TITLE CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH STE90-C11 FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: E; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LIGHT CHAIN OF FAB FRAGMENT; COMPND 7 CHAIN: L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: HEAVY CHAIN OF FAB FRAGMENT; COMPND 11 CHAIN: H; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS NEUTRALIZING ANTIBODIES, SARS-COV-2, RBD, ANTIVIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR T.KLUENEMANN,J.VAN DEN HEUVEL REVDAT 4 31-JAN-24 7B3O 1 JRNL REVDAT 3 04-AUG-21 7B3O 1 JRNL REVDAT 2 28-JUL-21 7B3O 1 COMPND SOURCE JRNL DBREF REVDAT 2 2 1 SEQADV REVDAT 1 16-DEC-20 7B3O 0 JRNL AUTH F.BERTOGLIO,V.FUHNER,M.RUSCHIG,P.A.HEINE,L.ABASSI, JRNL AUTH 2 T.KLUNEMANN,U.RAND,D.MEIER,N.LANGREDER,S.STEINKE,R.BALLMANN, JRNL AUTH 3 K.T.SCHNEIDER,K.D.R.ROTH,P.KUHN,P.RIESE,D.SCHACKERMANN, JRNL AUTH 4 J.KORN,A.KOCH,M.Z.CHAUDHRY,K.ESCHKE,Y.KIM,S.ZOCK-EMMENTHAL, JRNL AUTH 5 M.BECKER,M.SCHOLZ,G.M.S.G.MOREIRA,E.V.WENZEL,G.RUSSO, JRNL AUTH 6 H.S.P.GARRITSEN,S.CASU,A.GERSTNER,G.ROTH,J.ADLER,J.TRIMPERT, JRNL AUTH 7 A.HERMANN,T.SCHIRRMANN,S.DUBEL,A.FRENZEL,J.VAN DEN HEUVEL, JRNL AUTH 8 L.CICIN-SAIN,M.SCHUBERT,M.HUST JRNL TITL A SARS-COV-2 NEUTRALIZING ANTIBODY SELECTED FROM COVID-19 JRNL TITL 2 PATIENTS BINDS TO THE ACE2-RBD INTERFACE AND IS TOLERANT TO JRNL TITL 3 MOST KNOWN RBD MUTATIONS. JRNL REF CELL REP V. 36 09433 2021 JRNL REFN ESSN 2211-1247 JRNL PMID 34273271 JRNL DOI 10.1016/J.CELREP.2021.109433 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH F.BERTOGLIO,V.FUHNER,M.RUSCHIG,P.A.HEINE,L.ABASSI, REMARK 1 AUTH 2 T.KLUNEMANN,U.RAND,D.MEIER,N.LANGREDER,S.STEINKE,R.BALLMANN, REMARK 1 AUTH 3 K.T.SCHNEIDER,K.D.R.ROTH,P.KUHN,P.RIESE,D.SCHACKERMANN, REMARK 1 AUTH 4 J.KORN,A.KOCH,M.Z.CHAUDHRY,K.ESCHKE,Y.KIM,S.ZOCK-EMMENTHAL, REMARK 1 AUTH 5 M.BECKER,M.SCHOLZ,G.M.S.G.MOREIRA,E.V.WENZEL,G.RUSSO, REMARK 1 AUTH 6 H.S.P.GARRITSEN,S.CASU,A.GERSTNER,G.ROTH,J.ADLER,J.TRIMPERT, REMARK 1 AUTH 7 A.HERMANN,T.SCHIRRMANN,S.DUBEL,A.FRENZEL,J.VAN DEN HEUVEL, REMARK 1 AUTH 8 L.CICIN-SAIN,M.SCHUBERT,M.HUST REMARK 1 TITL A SARS-COV-2 NEUTRALIZING ANTIBODY SELECTED FROM COVID-19 REMARK 1 TITL 2 PATIENTS BINDS TO THE ACE2-RBD INTERFACE AND IS TOLERANT TO REMARK 1 TITL 3 MOST KNOWN RBD MUTATIONS. REMARK 1 REF CELL REP 09433 2021 REMARK 1 REFN ESSN 2211-1247 REMARK 1 PMID 34273271 REMARK 1 DOI 10.1016/J.CELREP.2021.109433 REMARK 1 REFERENCE 2 REMARK 1 AUTH F.BERTOGLIO,V.FUHNER,M.RUSCHIG,P.A.HEINE,U.RAND,T.KLUNEMANN, REMARK 1 AUTH 2 D.MEIER,N.LANGREDER,S.STEINKE,R.BALLMANN,K.SCHNEIDER, REMARK 1 AUTH 3 K.D.R.ROTH,P.KUHN,P.RIESE,D.SCHACKERMANN,J.KORN,A.KOCH, REMARK 1 AUTH 4 S.ZOCK-EMMENTHAL,M.BECKER,M.SCHOLZ,G.M.S.G.MOREIRA, REMARK 1 AUTH 5 E.V.WENZEL,G.RUSSO,H.S.GARRITSEN,S.CASU,A.GERSTNER,G.ROTH, REMARK 1 AUTH 6 A.HERMANN,T.SCHIRRMANN,S.DUBEL,A.FRENZEL,L.CICIN-SAIN, REMARK 1 AUTH 7 M.SCHUBERT,M.HUST REMARK 1 TITL A SARS-COV-2 NEUTRALIZING ANTIBODY SELECTED FROM COVID-19 REMARK 1 TITL 2 PATIENTS BY PHAGE DISPLAY IS BINDING TO THE ACE2-RBD REMARK 1 TITL 3 INTERFACE AND IS TOLERANT TO KNOWN RBD MUTATIONS REMARK 1 REF BIORXIV 2020 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2020.12.03.409318 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.10 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 63850 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1088 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.1000 - 4.0000 1.00 7980 138 0.1398 0.1750 REMARK 3 2 4.0000 - 3.1700 1.00 7868 137 0.1639 0.2178 REMARK 3 3 3.1700 - 2.7700 1.00 7881 136 0.1959 0.2125 REMARK 3 4 2.7700 - 2.5200 1.00 7820 135 0.2194 0.2612 REMARK 3 5 2.5200 - 2.3400 1.00 7841 136 0.2219 0.2645 REMARK 3 6 2.3400 - 2.2000 1.00 7763 135 0.2389 0.2745 REMARK 3 7 2.2000 - 2.0900 1.00 7806 136 0.2729 0.3316 REMARK 3 8 2.0900 - 2.0000 1.00 7803 135 0.3191 0.3638 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7B3O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1292112584. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-SEP-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, DESY REMARK 200 BEAMLINE : P11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63906 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 48.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.15900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : 1.89400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: 7BWY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 13.3% (W/V) POLYETHYLENE GLYCOL 6,000, REMARK 280 0.1M MES PH 5.6 0.24M TRI SODIUM CITRATE, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 97.87800 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.71000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 97.87800 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 43.71000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, L, H, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH H 435 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET E 329 REMARK 465 ALA E 330 REMARK 465 ASN E 331 REMARK 465 ILE E 332 REMARK 465 THR E 333 REMARK 465 ASN E 334 REMARK 465 LEU E 518 REMARK 465 HIS E 519 REMARK 465 ALA E 520 REMARK 465 PRO E 521 REMARK 465 ALA E 522 REMARK 465 THR E 523 REMARK 465 VAL E 524 REMARK 465 ALA E 525 REMARK 465 ALA E 526 REMARK 465 ALA E 527 REMARK 465 HIS E 528 REMARK 465 HIS E 529 REMARK 465 HIS E 530 REMARK 465 HIS E 531 REMARK 465 HIS E 532 REMARK 465 HIS E 533 REMARK 465 SER H 133 REMARK 465 THR H 134 REMARK 465 SER H 135 REMARK 465 GLY H 136 REMARK 465 ALA H 220 REMARK 465 ALA H 221 REMARK 465 ALA H 222 REMARK 465 HIS H 223 REMARK 465 HIS H 224 REMARK 465 HIS H 225 REMARK 465 HIS H 226 REMARK 465 HIS H 227 REMARK 465 HIS H 228 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU E 335 CG CD1 CD2 REMARK 470 ARG E 346 CG CD NE CZ NH1 NH2 REMARK 470 LYS E 386 CG CD CE NZ REMARK 470 GLU E 516 CG CD OE1 OE2 REMARK 470 LEU E 517 CG CD1 CD2 REMARK 470 LYS L 170 CG CD CE NZ REMARK 470 LYS L 189 CG CD CE NZ REMARK 470 GLN H 1 CG CD OE1 NE2 REMARK 470 LYS H 132 CG CD CE NZ REMARK 470 LYS H 217 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD1 HIS L 190 O HOH L 304 1.56 REMARK 500 OD1 ASP H 73 O HOH H 301 1.94 REMARK 500 OE2 GLU L 162 O HOH L 301 2.03 REMARK 500 OH TYR L 32 O HOH L 302 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA E 352 47.23 -109.15 REMARK 500 ASN E 360 65.09 39.82 REMARK 500 ASN E 422 -55.24 -129.68 REMARK 500 SER L 30 -128.35 52.17 REMARK 500 SER L 30 -128.21 51.84 REMARK 500 ALA L 51 -36.28 75.80 REMARK 500 SER L 128 -172.34 -63.72 REMARK 500 ASN L 139 70.17 53.41 REMARK 500 SER H 84 57.04 38.29 REMARK 500 SER H 84 56.24 39.16 REMARK 500 ASP H 147 60.95 61.83 REMARK 500 REMARK 500 REMARK: NULL DBREF 7B3O E 331 524 UNP P0DTC2 SPIKE_SARS2 331 524 DBREF 7B3O L 1 215 PDB 7B3O 7B3O 1 215 DBREF 7B3O H 1 228 PDB 7B3O 7B3O 1 228 SEQADV 7B3O MET E 329 UNP P0DTC2 INITIATING METHIONINE SEQADV 7B3O ALA E 330 UNP P0DTC2 EXPRESSION TAG SEQADV 7B3O ALA E 525 UNP P0DTC2 EXPRESSION TAG SEQADV 7B3O ALA E 526 UNP P0DTC2 EXPRESSION TAG SEQADV 7B3O ALA E 527 UNP P0DTC2 EXPRESSION TAG SEQADV 7B3O HIS E 528 UNP P0DTC2 EXPRESSION TAG SEQADV 7B3O HIS E 529 UNP P0DTC2 EXPRESSION TAG SEQADV 7B3O HIS E 530 UNP P0DTC2 EXPRESSION TAG SEQADV 7B3O HIS E 531 UNP P0DTC2 EXPRESSION TAG SEQADV 7B3O HIS E 532 UNP P0DTC2 EXPRESSION TAG SEQADV 7B3O HIS E 533 UNP P0DTC2 EXPRESSION TAG SEQRES 1 E 205 MET ALA ASN ILE THR ASN LEU CYS PRO PHE GLY GLU VAL SEQRES 2 E 205 PHE ASN ALA THR ARG PHE ALA SER VAL TYR ALA TRP ASN SEQRES 3 E 205 ARG LYS ARG ILE SER ASN CYS VAL ALA ASP TYR SER VAL SEQRES 4 E 205 LEU TYR ASN SER ALA SER PHE SER THR PHE LYS CYS TYR SEQRES 5 E 205 GLY VAL SER PRO THR LYS LEU ASN ASP LEU CYS PHE THR SEQRES 6 E 205 ASN VAL TYR ALA ASP SER PHE VAL ILE ARG GLY ASP GLU SEQRES 7 E 205 VAL ARG GLN ILE ALA PRO GLY GLN THR GLY LYS ILE ALA SEQRES 8 E 205 ASP TYR ASN TYR LYS LEU PRO ASP ASP PHE THR GLY CYS SEQRES 9 E 205 VAL ILE ALA TRP ASN SER ASN ASN LEU ASP SER LYS VAL SEQRES 10 E 205 GLY GLY ASN TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SEQRES 11 E 205 SER ASN LEU LYS PRO PHE GLU ARG ASP ILE SER THR GLU SEQRES 12 E 205 ILE TYR GLN ALA GLY SER THR PRO CYS ASN GLY VAL GLU SEQRES 13 E 205 GLY PHE ASN CYS TYR PHE PRO LEU GLN SER TYR GLY PHE SEQRES 14 E 205 GLN PRO THR ASN GLY VAL GLY TYR GLN PRO TYR ARG VAL SEQRES 15 E 205 VAL VAL LEU SER PHE GLU LEU LEU HIS ALA PRO ALA THR SEQRES 16 E 205 VAL ALA ALA ALA HIS HIS HIS HIS HIS HIS SEQRES 1 L 215 ASP ILE VAL MET THR GLN SER PRO SER PHE LEU SER ALA SEQRES 2 L 215 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 L 215 GLN GLY ILE SER SER TYR LEU ALA TRP TYR GLN GLN LYS SEQRES 4 L 215 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR ALA ALA SER SEQRES 5 L 215 THR LEU GLN SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 L 215 GLY SER GLY THR GLU PHE THR LEU THR ILE SER SER LEU SEQRES 7 L 215 GLN PRO GLU ASP PHE ALA THR TYR TYR CYS GLN GLN LEU SEQRES 8 L 215 ASN SER TYR PRO PRO PHE THR PHE GLY PRO GLY THR LYS SEQRES 9 L 215 VAL ASP ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 L 215 ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR SEQRES 11 L 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 L 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 L 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 L 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 L 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 L 215 GLU VAL THR HIS GLN GLY LEU ARG SER PRO VAL THR LYS SEQRES 17 L 215 SER PHE ASN ARG GLY GLU CYS SEQRES 1 H 228 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 228 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 228 LEU THR VAL SER SER ASN TYR MET SER TRP VAL ARG GLN SEQRES 4 H 228 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER VAL ILE TYR SEQRES 5 H 228 SER GLY GLY SER THR TYR TYR ALA ASP SER VAL LYS GLY SEQRES 6 H 228 ARG PHE THR ILE SER ARG ASP ASP SER LYS ASN THR LEU SEQRES 7 H 228 TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR ALA SEQRES 8 H 228 VAL TYR TYR CYS ALA ARG ASP VAL ALA ASP ALA PHE ASP SEQRES 9 H 228 ILE TRP GLY GLN GLY THR MET VAL THR VAL SER SER ALA SEQRES 10 H 228 SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SER SEQRES 11 H 228 SER LYS SER THR SER GLY GLY THR ALA ALA LEU GLY CYS SEQRES 12 H 228 LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER SEQRES 13 H 228 TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR PHE SEQRES 14 H 228 PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SEQRES 15 H 228 SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR GLN SEQRES 16 H 228 THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR SEQRES 17 H 228 LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS ALA ALA SEQRES 18 H 228 ALA HIS HIS HIS HIS HIS HIS HET NAG A 1 26 HET NAG A 2 27 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG 2(C8 H15 N O6) FORMUL 5 HOH *427(H2 O) HELIX 1 AA1 PHE E 338 ASN E 343 1 6 HELIX 2 AA2 SER E 349 TRP E 353 5 5 HELIX 3 AA3 ASP E 364 SER E 371 1 8 HELIX 4 AA4 PRO E 384 ASN E 388 5 5 HELIX 5 AA5 ASP E 405 ILE E 410 5 6 HELIX 6 AA6 GLY E 416 ASN E 422 1 7 HELIX 7 AA7 SER E 438 SER E 443 1 6 HELIX 8 AA8 GLY E 502 TYR E 505 5 4 HELIX 9 AA9 GLN L 79 PHE L 83 5 5 HELIX 10 AB1 SER L 122 SER L 128 1 7 HELIX 11 AB2 LYS L 184 LYS L 189 1 6 HELIX 12 AB3 THR H 28 ASN H 32 5 5 HELIX 13 AB4 ARG H 86 THR H 90 5 5 HELIX 14 AB5 SER H 159 ALA H 161 5 3 HELIX 15 AB6 SER H 190 LEU H 192 5 3 HELIX 16 AB7 LYS H 204 ASN H 207 5 4 SHEET 1 AA1 5 ASN E 354 ILE E 358 0 SHEET 2 AA1 5 VAL E 395 ARG E 403 -1 O VAL E 395 N ILE E 358 SHEET 3 AA1 5 PRO E 507 PHE E 515 -1 O VAL E 512 N ASP E 398 SHEET 4 AA1 5 GLY E 431 ASN E 437 -1 N ILE E 434 O VAL E 511 SHEET 5 AA1 5 THR E 376 TYR E 380 -1 N TYR E 380 O GLY E 431 SHEET 1 AA2 2 LEU E 452 ARG E 454 0 SHEET 2 AA2 2 LEU E 492 SER E 494 -1 O GLN E 493 N TYR E 453 SHEET 1 AA3 2 TYR E 473 GLN E 474 0 SHEET 2 AA3 2 CYS E 488 TYR E 489 -1 O TYR E 489 N TYR E 473 SHEET 1 AA4 4 MET L 4 SER L 7 0 SHEET 2 AA4 4 VAL L 19 ALA L 25 -1 O ARG L 24 N THR L 5 SHEET 3 AA4 4 GLU L 70 ILE L 75 -1 O LEU L 73 N ILE L 21 SHEET 4 AA4 4 PHE L 62 GLY L 66 -1 N SER L 63 O THR L 74 SHEET 1 AA5 6 PHE L 10 ALA L 13 0 SHEET 2 AA5 6 THR L 103 ILE L 107 1 O LYS L 104 N LEU L 11 SHEET 3 AA5 6 THR L 85 GLN L 90 -1 N TYR L 86 O THR L 103 SHEET 4 AA5 6 LEU L 33 GLN L 38 -1 N GLN L 38 O THR L 85 SHEET 5 AA5 6 LYS L 45 TYR L 49 -1 O LEU L 47 N TRP L 35 SHEET 6 AA5 6 THR L 53 LEU L 54 -1 O THR L 53 N TYR L 49 SHEET 1 AA6 4 PHE L 10 ALA L 13 0 SHEET 2 AA6 4 THR L 103 ILE L 107 1 O LYS L 104 N LEU L 11 SHEET 3 AA6 4 THR L 85 GLN L 90 -1 N TYR L 86 O THR L 103 SHEET 4 AA6 4 THR L 98 PHE L 99 -1 O THR L 98 N GLN L 90 SHEET 1 AA7 4 SER L 115 PHE L 119 0 SHEET 2 AA7 4 THR L 130 PHE L 140 -1 O LEU L 136 N PHE L 117 SHEET 3 AA7 4 TYR L 174 SER L 183 -1 O TYR L 174 N PHE L 140 SHEET 4 AA7 4 SER L 160 VAL L 164 -1 N GLN L 161 O THR L 179 SHEET 1 AA8 4 ALA L 154 LEU L 155 0 SHEET 2 AA8 4 ALA L 145 VAL L 151 -1 N VAL L 151 O ALA L 154 SHEET 3 AA8 4 VAL L 192 HIS L 199 -1 O GLU L 196 N GLN L 148 SHEET 4 AA8 4 VAL L 206 ASN L 211 -1 O VAL L 206 N VAL L 197 SHEET 1 AA9 4 GLN H 3 SER H 7 0 SHEET 2 AA9 4 LEU H 18 SER H 25 -1 O ALA H 23 N VAL H 5 SHEET 3 AA9 4 THR H 77 MET H 82 -1 O MET H 82 N LEU H 18 SHEET 4 AA9 4 PHE H 67 ASP H 72 -1 N THR H 68 O GLN H 81 SHEET 1 AB1 6 LEU H 11 VAL H 12 0 SHEET 2 AB1 6 THR H 110 VAL H 114 1 O THR H 113 N VAL H 12 SHEET 3 AB1 6 ALA H 91 VAL H 99 -1 N TYR H 93 O THR H 110 SHEET 4 AB1 6 TYR H 33 GLN H 39 -1 N VAL H 37 O TYR H 94 SHEET 5 AB1 6 LEU H 45 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 AB1 6 THR H 57 TYR H 59 -1 O TYR H 58 N VAL H 50 SHEET 1 AB2 4 LEU H 11 VAL H 12 0 SHEET 2 AB2 4 THR H 110 VAL H 114 1 O THR H 113 N VAL H 12 SHEET 3 AB2 4 ALA H 91 VAL H 99 -1 N TYR H 93 O THR H 110 SHEET 4 AB2 4 ALA H 102 TRP H 106 -1 O ALA H 102 N VAL H 99 SHEET 1 AB3 4 SER H 123 LEU H 127 0 SHEET 2 AB3 4 THR H 138 TYR H 148 -1 O LEU H 144 N PHE H 125 SHEET 3 AB3 4 TYR H 179 PRO H 188 -1 O TYR H 179 N TYR H 148 SHEET 4 AB3 4 VAL H 166 THR H 168 -1 N HIS H 167 O VAL H 184 SHEET 1 AB4 4 SER H 123 LEU H 127 0 SHEET 2 AB4 4 THR H 138 TYR H 148 -1 O LEU H 144 N PHE H 125 SHEET 3 AB4 4 TYR H 179 PRO H 188 -1 O TYR H 179 N TYR H 148 SHEET 4 AB4 4 VAL H 172 LEU H 173 -1 N VAL H 172 O SER H 180 SHEET 1 AB5 3 THR H 154 TRP H 157 0 SHEET 2 AB5 3 ILE H 198 HIS H 203 -1 O ASN H 200 N SER H 156 SHEET 3 AB5 3 THR H 208 LYS H 213 -1 O VAL H 210 N VAL H 201 SSBOND 1 CYS E 336 CYS E 361 1555 1555 2.04 SSBOND 2 CYS E 379 CYS E 432 1555 1555 2.06 SSBOND 3 CYS E 480 CYS E 488 1555 1555 2.10 SSBOND 4 CYS L 23 CYS L 88 1555 1555 2.12 SSBOND 5 CYS L 135 CYS L 195 1555 1555 2.01 SSBOND 6 CYS L 215 CYS H 219 1555 1555 2.03 SSBOND 7 CYS H 22 CYS H 95 1555 1555 2.09 SSBOND 8 CYS H 143 CYS H 199 1555 1555 2.05 LINK ND2 ASN E 343 C1 NAG A 1 1555 1555 1.44 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.45 CISPEP 1 SER L 7 PRO L 8 0 -7.33 CISPEP 2 TYR L 94 PRO L 95 0 2.72 CISPEP 3 TYR L 141 PRO L 142 0 1.72 CISPEP 4 PHE H 149 PRO H 150 0 -3.17 CISPEP 5 GLU H 151 PRO H 152 0 1.70 CRYST1 195.756 87.420 57.059 90.00 100.61 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005108 0.000000 0.000957 0.00000 SCALE2 0.000000 0.011439 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017831 0.00000